Fadini, Gian Paolo http://orcid.org/0000-0002-6510-2097
Frison, Vera
Rigato, Mauro
Morieri, Mario Luca
Simioni, Natalino
Tadiotto, Federica
D’Ambrosio, Michele
Paccagnella, Agostino
Lapolla, Annunziata
Avogaro, Angelo
Funding for this research was provided by:
University of Padova
Article History
Received: 18 September 2019
Accepted: 24 October 2019
First Online: 31 October 2019
Compliance with ethical standards
:
: GPF received grant support, lecture or advisory board fees from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Mundipharma, NovoNordisk, Sanofi, Genzyme, Abbott, Novartis, Merck Sharp and Dohme. VF served as consultant for NovoNordisk. MR received lecture and advisory board fees from AstraZeneca, Boehringer Ingelheim, Novonordisk and Sanofi-Aventis. NS received lecture or consultancy fees from AstraZeneca, Boehringer–Lilly, Novartis, NovoNordisk, Sanofi-Aventis, Takeda, Merck Sharp and Dohme, Abbott and research support from NovoNordisk. AL received grant support, lectures or advisory board fees from Novo Nordisk, Sanofi, Abbott and Eli Lilly. AA received research grants, lecture or advisory board fees from Merck Sharp and Dome, AstraZeneca, Novartis, Boehringer Ingelheim, Sanofi, Mediolanum, Janssen, Novo Nordisk. FT, AP and MDA declare no conflict of interest.
: The study protocol was approved by the local ethical committee of each participating center.
: In agreement with National regulations retrospective studies and on data protection and privacy, no informed consent was collected because the database was anonymous.